Abbott Says Humira Gained Market Share in Crohn's, Psoriasis - San Francisco Chronicle

Kansas City prima Abbott Says Humira Gained Market Share in Crohn's, Psoriasis San Francisco account July 20 (Bloomberg) -- Abbott Laboratories' top-selling Humira drug surged to type A 25 percent revenue increase in the second fourth by wresting sales from rival treatments for disease of the skin , Crohn's disease and arthritis, Chief Financial serviceman Thomas Freyman ... Abbott Says Humira Gained activity Share in Crohn's, disease of the skin Bloomberg Abbott Labs 2Q profit grows with emerging markets The Associated estate Abbott posts 50% Q2 profit growth, revenues outgrowth on pharmaceuticals Proactive Investors USA & Canada each 206 news articles » Link To Article